Superficial fungal infection segment is expected to drive the market for antifungal drugs over the forecast period by infection type segment.

 

According to a new market research study titled ‘Antifungal Drugs Market to 2027 – Global Analysis and Forecasts by Infection Type, Drug Type, Therapeutic Indication, Dosage Form and Geography. The global Antifungal Drugs market is expected to reach US$ 13,524.2 Mn in 2027 from US$ 10,182.3 Mn in 2018. The market is estimated to grow with a CAGR of 3.2% from 2019-2027. The report highlights the trends prevalent in the global Antifungal Drugs market and the factors driving the market along with those that act as challenges to its growth.

 

Global Antifungal Drugs market was segmented by infection type, drug type, therapeutic indication, and dosage form. On the basis of the infection type, the market is segmented as superficial fungal infection and systemic antifungal infection. Based on the drug type, the Antifungal Drugs market is segmented into echinocandins, azoles, polyenes, allylamines, and others. On the basis of the therapeutic indication, the Antifungal Drugs market is segmented into aspergillosis, dermatophytosis, candidiasis, and others. By dosage form, the market is segmented into drugs, ointment, powder, and others.

 

The market for Antifungal Drugs is expected to grow significantly due to factors such as rising incidences for the fungal infection of the skin, nails and hair, increasing incidences of cancers, HIV, and hospital-acquired infections and favorable government initiatives to combat the antifungal diseases are likely to drive the growth of the Antifungal Drugs market. However, lack of awareness regarding the fungal infections may restrict the growth of Antifungal Drugs market.

 

The major players operating in the Antifungal Drugs market include, Pfizer Inc., Sanofi S.A., Gilead Sciences, Inc., Merck And Co., Inc., Scynexis Inc., Novartis International AG, Abbott Laboratories, Bayer AG, Glenmark Pharmaceutical, and Glaxosmithkline Plc. The market has carried out various organic and inorganic growth strategies in the market which has assisted in strengthening their product offering in the market.

 

 

The report segments the global Antifungal Drugs market as follows:

 

Global Antifungal Drugs Market – By Infection Type

  • Superficial Fungal Infection
  • Systemic Fungal Infection

Global Antifungal Drugs Market – By Drug Type

  • Echinocandins
  • Azoles
  • Polyenes
  • Allylamines
  • Others

Global Antifungal Drugs Market – By Therapeutic Indication

  • Aspergillosis  
  • Dermatophytosis
  • Candidiasis
  • Others

Global Antifungal Drugs Market – By Dosage Form

  • Drugs
  • Ointment
  • Powder
  • Others

Global Antifungal Drugs Market – By Geography

  • North America
    • U.S
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • U.K
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
  • South & Central America
    • Brazil
    • Argentina

 

Contact Us

Contact Person: Sameer Joshi

Phone: +1-646-491-9876

Email Id: sales@theinsightpartners.com